•  
  •  
  •  
  •  

2025-09-30 05:36:05

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Umiya Mobile Limited Strengthens Market Presence with 36 New Stores Post IPO
  • Avantel Ltd to inaugurate new facility on Oct 2, 2025
  • Solarium Green Energy Ltd receives orders worth Rs. 18.77 crores
  • Capricorn Systems Global Solutions Ltd receives order for supply of broken rice
  • Anand Rayons Ltd receives approval for STAPII trademark

Keywords Selected:  INE406A01037

Research

  • Aurobindo Pharma - Entry into India - a little too late?

Stock Report

  • Fire Incident at APL Healthcare Ltd's Unit 4 at Naidupeta
  • CuraTeQ Biologics Pvt Ltd completes Phase 3 Clinical Study for Denosumab Biosimilar
  • Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
  • CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
  • Aurobindo Pharma Ltd to invest in Swarnaakshu Solar Power Pvt Ltd, purchase captive solar power
  • Lyfius Pharma Pvt Ltd restarts operations at Penicillin-G manufacturing facility
  • CuraTeQ Biologics receives positive opinion for biosimilar Dazublys® from EMA
  • Eugia Pharma receives USFDA Approval for Dasatinib Tablets
  • Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
  • Aurolife Pharma LLC gets 11 observations from USFDA for Raleigh Plant
  • CuraTeQ Biologics completes a successful Phase 1 Pharmacokinetics study of Denosumab BP16, a proposed biosimilar to Prolia® and Xgeva®
  • CuraTeQ Biologics received Marketing Authorization for Dyrupeg™, a pegylated filgrastim biosimilar
  • Apitoria Pharma Pvt Ltd's API manufacturing facility classified as VAI by USFDA
  • Auro Vaccines Pvt Ltd terminates license agreement with Hilleman Laboratories Singapore Pte Ltd
  • USFDA classifies Aurobindo Pharma Inc's warehouse as OAI
  • CuraTeQ Biologics receives approval for oncology biosimilar Bevqolva from UK's MHRA
  • US FDA completes inspection at Unit V of Apitoria Pharma Private Limited
  • CuraTeQ Biologics receives positive opinion for biosimilar Zefylti
  • Eugia Pharma receives USFDA Approval for Pazopanib Tablets, 200 mg
  • Aurobindo Pharma receives USFDA Approval for Cephalexin Tablets USP, 250 mg and 500 mg
  • Apitoria Pharma Pvt Ltd gets Form 483 with 10 observations from US FDA
  • Aurobindo Pharma Ltd to acquire balance 49% stake in GLS Pharma Ltd
  • Eugia Steriles Pvt Ltd receives EIR from USFDA for new injectable facility
  • LIC reduces stake in Aurobindo Pharma Ltd

Latest Post

  • Umiya Mobile Limited Strengthens Market Presence with 36 New Stores Post IPO
  • Avantel Ltd to inaugurate new facility on Oct 2, 2025
  • Solarium Green Energy Ltd receives orders worth Rs. 18.77 crores
  • Capricorn Systems Global Solutions Ltd receives order for supply of broken rice
  • Anand Rayons Ltd receives approval for STAPII trademark


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024